Skip to main content
Premium Trial:

Request an Annual Quote

DeCode and Roche Sign 5-Year Diagnostics Development Deal

NEW YORK, March 6 – DeCode and Roche Diagnostics have signed on to a five-year alliance to jointly develop DNA-based diagnostic tools using DeCode’s genomics research and informatics technology, the companies said Tuesday.

Under the agreement, Roche, of Basel, Switzerland, will provide research funding and milestone payments to DeCode, and will share product royalties with the Reykjavik, Iceland-based genomics company. The parties did not disclose further financial details of the agreement, but said they will begin work on the diagnostics immediately.

"It is very exciting to be able to bring together our gene research and bioinformatics know-how for the development of the next generation in diagnostic tools and decision-support systems,” said Kari Stefansson, CEO of DeCode, in a statement. “We will also be working with a trusted partner and the world leader in the field of diagnostics." 

This alliance follows the four-year collaboration DeCode established with Roche in 1998 to discover novel disease-related genes. Under this alliance DeCode has provided Roche with gene targets related to Alzheimer’s disease, arterial disease of the arms and legs, osteoporosis, pre-eclampsia, schizophrenia, and stroke. Roche has used these gene targets in developing new medications.

In November, DeCode launched two subsidiaries, DeCode Cancer for developing cancer diagnostic and therapeutic products; and EnCode for pharmacogenomic studies.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.